HomeComparePTRA vs JNJ

PTRA vs JNJ: Dividend Comparison 2026

PTRA yields 2985.07% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PTRA wins by $433539968075.10M in total portfolio value
10 years
PTRA
PTRA
● Live price
2985.07%
Share price
$0.07
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$433539968075.12M
Annual income
$406,736,225,519,142,500.00
Full PTRA calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — PTRA vs JNJ

📍 PTRA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPTRAJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PTRA + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PTRA pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PTRA
Annual income on $10K today (after 15% tax)
$253,731.34/yr
After 10yr DRIP, annual income (after tax)
$345,725,791,691,271,200.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, PTRA beats the other by $345,725,791,691,270,460.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PTRA + JNJ for your $10,000?

PTRA: 50%JNJ: 50%
100% JNJ50/50100% PTRA
Portfolio after 10yr
$216769984037.57M
Annual income
$203,368,112,759,571,680.00/yr
Blended yield
93.82%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PTRA
Analyst Ratings
2
Buy
4
Hold
1
Sell
Consensus: Hold
Price Target
$7.00
+10347.8% upside vs current
Range: $7.00 — $7.00
Altman Z
-2.8
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PTRA buys
0
JNJ buys
0
No recent congressional trades found for PTRA or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPTRAJNJ
Forward yield2985.07%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$433539968075.12M$20.0K
Annual income after 10y$406,736,225,519,142,500.00$827.78
Total dividends collected$431686299125.80M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$7.00$228.73

Year-by-year: PTRA vs JNJ ($10,000, DRIP)

YearPTRA PortfolioPTRA Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$309,207$298,507.46$10,676$355.77+$298.5KPTRA
2$8,957,089$8,626,236.93$11,407$389.39+$8.95MPTRA
3$243,120,454$233,536,368.64$12,198$426.53+$243.11MPTRA
4$6,184,279,490$5,924,140,604.30$13,056$467.62+$6184.27MPTRA
5$147,451,722,719$140,834,543,664.57$13,987$513.12+$147451.71MPTRA
6$3,296,013,356,428$3,138,240,013,119.13$14,998$563.56+$3296013.34MPTRA
7$69,087,118,460,072$65,560,384,168,694.19$16,098$619.52+$69087118.44MPTRA
8$1,358,221,282,082,432$1,284,298,065,330,154.50$17,295$681.69+$1358221282.07MPTRA
9$25,050,226,687,827,436$23,596,929,915,999,230.00$18,599$750.82+$25050226687.81MPTRA
10$433,539,968,075,117,900$406,736,225,519,142,500.00$20,022$827.78+$433539968075.10MPTRA

PTRA vs JNJ: Complete Analysis 2026

PTRAStock

Proterra Inc. provides commercial vehicles in the United States, the European Union, Canada, Australia, and Japan. It operates through Proterra Powered and Energy and Proterra Transit business units. The Proterra Powered and Energy business unit designs, develops, manufactures, sells, and integrates battery systems and electrification solutions into vehicles for commercial vehicle OEM customers serving delivery trucks, school buses, coach buses, construction and mining equipment, and other applications. It also provides turnkey fleet-scale, high-power charging solutions and software services, ranging from fleet and energy management software-as-a-service to fleet planning, hardware, infrastructure, installation, utility engagement, and charging optimization. The Proterra Transit business unit designs, develops, manufactures, and sells electric transit buses as an OEM for North American public transit agencies, airports, universities, and other commercial transit fleets. Proterra Inc. was incorporated in 2004 and is headquartered in Burlingame, California.

Full PTRA Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this PTRA vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PTRA vs SCHDPTRA vs JEPIPTRA vs OPTRA vs KOPTRA vs MAINPTRA vs ABBVPTRA vs MRKPTRA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.